Arcus Biosciences price target lowered to $25 from $35 at Barclays
PremiumThe FlyArcus Biosciences price target lowered to $25 from $35 at Barclays
2M ago
Arcus Biosciences drops 6% after Roche lung cancer failure
Premium
The Fly
Arcus Biosciences drops 6% after Roche lung cancer failure
3M ago
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
Premium
The Fly
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
3M ago
Gilead, Arcus announce new data from Cohort B of ARC-9 mCRC study
PremiumThe FlyGilead, Arcus announce new data from Cohort B of ARC-9 mCRC study
4M ago
Gilead, Arcus announce data supporting ongoing Phase 3 STAR-221 study
Premium
The Fly
Gilead, Arcus announce data supporting ongoing Phase 3 STAR-221 study
4M ago
Arcus Biosciences reports Q1 EPS (5c), consensus (95c)
Premium
The Fly
Arcus Biosciences reports Q1 EPS (5c), consensus (95c)
4M ago
Arcus Biosciences Announces Anti-TIGIT Program Update
PremiumCompany AnnouncementsArcus Biosciences Announces Anti-TIGIT Program Update
8M ago
Arcus Biosciences Announces Board Reshuffle and New Appointment
Premium
Company Announcements
Arcus Biosciences Announces Board Reshuffle and New Appointment
8M ago
Arcus Biosciences Sells Equity to Gilead Under Section 4(a)(2)
Premium
Company Announcements
Arcus Biosciences Sells Equity to Gilead Under Section 4(a)(2)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100